Long-term use of three-monthly injectable contraceptive DMPA not linked to breast cancer.
D000349:Africa; D017954:Africa South of the Sahara; D000351:Africa, Eastern; D000569:Americas; D001208:Asia; D001210:Asia, Southeastern; D001943:Breast Neoplasms; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D003906:Developing Countries; D004194:Disease; D005193:Family Planning Services; D006262:Health; D007267:Injections; D007630:Kenya; D007843:Latin America; D017258:Medroxyprogesterone Acetate; D008800:Mexico; D009369:Neoplasms; D009520:New Zealand; D009656:North America; D010139:Pacific Islands; D011634:Public Health; D012449:Safety; D013785:Thailand
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D017258:Medroxyprogesterone Acetate